- FNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting
- Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
- Rallybio Announces FNAIT Systematic Literature Review to be Presented at the AMCP 2024 Annual Meeting
- Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results
- Rallybio to Present at the TD Cowen 44th Annual Health Care Conference
- Rallybio Announces Portfolio Prioritization and Provides Corporate Update
More ▼
Key statistics
On Friday, Rallybio Corp (RLYB:NSQ) closed at 1.83, 49.39% above the 52 week low of 1.23 set on Feb 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.87 |
---|---|
High | 1.89 |
Low | 1.78 |
Bid | 1.82 |
Offer | 1.92 |
Previous close | 1.83 |
Average volume | 269.47k |
---|---|
Shares outstanding | 37.81m |
Free float | 33.08m |
P/E (TTM) | -- |
Market cap | 69.20m USD |
EPS (TTM) | -1.84 USD |
Data delayed at least 15 minutes, as of May 03 2024 21:00 BST.
More ▼